Stay updated with breaking news from 00484m10. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
StockNews.com started coverage on shares of Acorda Therapeutics (NASDAQ:ACOR – Free Report) in a research note released on Thursday morning. The brokerage issued a buy rating on the biopharmaceutical company’s stock. Acorda Therapeutics Stock Up 8.8 % Shares of NASDAQ ACOR opened at $14.80 on Thursday. Acorda Therapeutics has a 12-month low of $8.98 and […]
StockNews.com assumed coverage on shares of Acorda Therapeutics (NASDAQ:ACOR – Free Report) in a research note issued to investors on Thursday morning. The firm issued a buy rating on the biopharmaceutical company’s stock. Acorda Therapeutics Stock Up 8.8 % Shares of NASDAQ:ACOR opened at $14.80 on Thursday. The company has a debt-to-equity ratio of 3.07, […]
Acorda Therapeutics, Inc. (NASDAQ:ACOR – Get Free Report) shares crossed above its 200-day moving average during trading on Wednesday . The stock has a 200-day moving average of $12.75 and traded as high as $13.50. Acorda Therapeutics shares last traded at $13.38, with a volume of 11,217 shares. Analysts Set New Price Targets Separately, StockNews.com […]
StockNews.com assumed coverage on shares of Acorda Therapeutics (NASDAQ:ACOR – Free Report) in a research report released on Wednesday. The firm issued a buy rating on the biopharmaceutical company’s stock. Acorda Therapeutics Trading Up 6.2 % Shares of Acorda Therapeutics stock opened at $13.29 on Wednesday. The stock’s 50-day simple moving average is $10.41 and […]
Acadian Asset Management LLC lessened its holdings in Acorda Therapeutics, Inc. (NASDAQ:ACOR – Free Report) by 95.0% during the second quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 34,131 shares of the biopharmaceutical company’s stock after selling 648,507 shares during the quarter. Acadian Asset Management LLC […]